Hillhouse Investment's Biotechnology Portfolio

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Metanovas develops drugs, dietary supplements, functional foods, and cosmetics using AI technology.

MiAlgae is a new-age microalgal production company .

UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Dishi Medical is a company that manufactures Ophthalmic Medical Devices and other micro-assisted robots supported by biotechnology.

Designing innovative technologies focused on accelerating global access to biotherapeutics.

MAXVAX aims to provide novel vaccine development and commercialization.

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Starna Therapeutics developing tissue selective targeted RNA therapies for unmet patient needs.

GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors.

Changjin Biotechnology specializes in the research and development of edible microbial synthetic proteins for the food sector.

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

Kelun Biotech is a biopharmaceutical company that focuses on the research and development, production and sales of innovative drugs.

Immorna specializes in the production of RNA-based therapeutics.

IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.

Targeting One is an in-vitro diagnostic product developer.

Qitan Technology is a Developer of a genome sequencing technology.

Hopson Technology is a natural product synthesis technology developer.

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

Bluepha is a biomanufacturing and material innovation company providing breakthrough products with competitive differentiation.

Deyun Kangrui is a bio-medical high-tech enterprise that integrates R&D and the production of full-chain single-cell multi-omics technology.

Proton Bio is mainly engaged in gene and cell therapy CDMO service provider, focusing on the field of gene and cell therapy.

Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds.

Helixon is a biotechnology company that accelerates novel drug discovery for unmet medical needs.

HuidaGene is a global clinical-stage biotechnology company pioneering innovative gene therapies for neurology and ophthalmology.